◂ Announcements

Apr 1, 2019ACQUISITIONUnited States

Johnson & Johnson closes $3.4bn acquisition of Auris Health

Johnson & Johnson subsidiary Ethicon closed a $3.4bn acquisition of surgical robotics developer Auris Health. The deal includes up to $2.35bn in additional contingent payments.

Value

$3.40B

Status

Completed

Productssurgical roboticsMonarch Platform

CompaniesJohnson & Johnson acquirer Auris Health target

Sectors#Medical Devices

“Johnson & Johnson (J&J) subsidiary Ethicon has closed a $3.4bn acquisition of surgical robotics developer Auris Health.”medicaldevice-network.com

1 source
medicaldevice-network.comJ&J concludes $3.4bn Auris Health acquisition dealDivya TirumalarajuApr 1, 2019

Summarized from public sources; check the original articles before acting on it.

More from Johnson & Johnson

profile ▸

Nov 1, 2022ACQUISITION$16.6B
Johnson & Johnson to acquire Abiomed in $16.6B deal
Johnson & Johnson acquirer Abiomed target jnj.com
Jul 8, 2021ACQUISITIONUnited States$3.40B
Johnson & Johnson to acquire Auris Health for $3.4 billion
Johnson & Johnson acquirer Ethicon acquirer accuprec.com
Apr 29, 2021NEW FACILITYBarcelona, Spain, Spainops Q2 2021
Reig Jofre new plant in Barcelona to produce J&J COVID-19 vaccine
Reig Jofre Johnson & Johnson customer reuters.com
Oct 15, 2020EXPANSIONLatina, Italy, Italyops 15 Oct 2020
Janssen doubles automated production line at Latina plant
Johnson & Johnson Janssen Italia partner jnj.com
Mar 25, 2020ACQUISITION$400.0M
EU opens in-depth probe into J&J's $400M purchase of Takeda's surgical patch
Johnson & Johnson acquirer Takeda Pharmaceuticals Company Limited target law360.com
Dec 20, 2019ACQUISITIONUnited States
Johnson & Johnson to acquire remaining stake in Verb Surgical
Johnson & Johnson acquirer Verily partner jnj.com jnjmedtech.com fiercebiotech.com

Loading…

Johnson & Johnson closes $3.4bn acquisition of Auris Health · Endata